
    
      A total of 226 H. pylori-infected, treatment-naive patients will be enrolled in this
      randomized controlled clinical trial. Patients will be randomly allocated into 2 groups:
      Esomeprazole 20 mg, clarithromycin 500 mg, amoxicillin 1000 mg, and bismuth potassium citrate
      200 mg twice daily for 14 days.Esomeprazole 20 mg, minocycline 100 mg, amoxicillin 1000 mg,
      and bismuth potassium citrate 200 mg twice daily for 14 days. Eradication rates will be
      assessed 4-12 weeks after treatment.
    
  